1DELA CORTE- RODRIGUEZ H, RODRIGUEZ- MERCHAN EC. The current role of orthoses in treating haemophilic arthropathy [ J ]. Hae- mophilia,2015, [ Epub ahead of print ].
2SIMPSON ML, VALENTINO LA. Management of joint bleeding in he- mophilia [ J ]. Expert Rev Hemato1,2012,5 (4) :459-468.
3VAN- MEEGEREN M. Update on pathogenesis of the bleeding joint : an interplay between inflammatory and degenerative pathways [ J ]. Haemophilia ,2010,16 ( 5 ) : 121-123.
4RODRIGUEZ-MERCHAN EC. Orthopaedic problems about the ankle in Hemophilia[ J]. J Foot Ankle Surg,2012,51 (6) :772-776.
5MURATA M,YUDOH K,MASUKO K. The potential roal of vascular endothelial growth factor(VEFG) in cartilage:how the angiogenic fac- tor could be involved in the pathogenesis of osteoarthritis[ J] ? Osteo- arthritis Cartilage ,2008,16 ( 3 ) :279-286.
8OVLISEN K, KRISTENSEN AT, JENSEN AL, et al. IL- 1 b, IL-6, KCand MCP-1 are elevated in synovial fluid from haemophilic mice with experimentally induced haemarthrosis[ J]. Haemophlia ,2009,15 ( 3 ) : 802-810.
9ACHARYA SS,KAPLAN RN,MACDONALD D, et al. Neoangiogene- sis contributes to the development of hemophilic synovitis [ J 1. Blood, 2011,117(8) :2484-2493.
10HASHIZUME M, HAYAKAWA N, MIHARA M. IL-6 trans- signalling directly induces RANKL on fibroblast- like synovial ceils and is in- volved in RANKL induction by TNF-alpha and IL-17. Rheumatology [ J ]. Rheumatology, 20008,47 ( 11 ) : 1635-1640.
